Company profile
Minerva Surgical, Inc.
OTC: UTRS · Healthcare · Medical - Devices
#436 of 1,418 Healthcare companies by revenue36th-percentile growth
EA Score
——FH —DQ 33GM —SS 30
v0.1 · 25/100 weight · pillars only
↑ workforce scale, filing timeliness · ↓ market scale, disclosure history
Methodology →Revenue TTM
$51.7M
Rev growth YoY (TTM)
+3.1%
Net income (FY)
-$34.1M
Employees
174
as of 2026-08-31
Market cap
$888
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$50.3M$50.3M2022
Net income-$34.1M-$34.1M2022
Operating income-$30.9M-$30.9M2022
Total assets$68.9M$68.9M2022
Liabilities$51.7M$51.7M2022
Equity$17.2M$17.2M2022
Revenue trend
FY2021 – FY2022 · USD
FY21
FY21
FY22
Revenue by segment
Filed disclosures · FY2021
By product
Warranty Service100%
By geography
Not disclosed.
The read
What is Minerva Surgical, Inc.’s revenue?
Minerva Surgical, Inc. booked $50.3M in FY2022 revenue, contracting 3.5% year over year — slower than 64% of Healthcare companies we track, at a -67.8% net margin.
Peers · Healthcare
LENSAR Inc55CCipher Pharmaceuticals Inc.84B+Carlsmed, Inc.54DCharlotte's Web Holdings, Inc.44DLexicon Pharmaceuticals, Inc.59CBioqual, Inc.——Neighbors
Santa Clara →Key facts
CEODarin Hammers
SectorHealthcare
IndustryMedical - Devices
HeadquartersSanta Clara, CA
ExchangeOTC: UTRS
Employees174
IPO date2021-10-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.